1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > World Generic Markets 29 FEBRUARY 2016

World Generic Markets 29 FEBRUARY 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Merck KGaA Trial Highlights Growing Potential Biosimilar Adalimumab Market
Industry Trend Analysis - More Work Remains To Be Done On Canadian Generic Drug Pricing
Industry Brief - Teva Canada Launches Tobramycin Inhalation Solution
Industry Brief - Mylan's Fluticasone+salmeterol ANDA Accepted By FDA
Industry Brief - Lannett Gains Sumatriptan Nasal Spray Approval
Industry Brief - ANI And Dexcel Gain Donepezil Approval
Industry Brief - FDA Approves Intellipharmaceutics' Levetiracetam
Industry Trend Analysis - Hikma On Track To Boost US Generic Injectables Presence
Industry Brief - FDA Approves Teligent's Desoximetasone Ointment
Industry Brief - FDA Accepts Allergan's Rifaximin ANDA For Filing
Industry Trend Analysis - Billion Dollar Revenues Beckoning For Impax
Industry Trend Analysis - Generic Drugs Are Not Contributing To Price Rises
Industry Brief - Sandoz Acquires Pfizer's Infliximab In EEA
Industry Trend Analysis - Abbott Acquisition Positions Mylan To Overtake Sandoz In 2016
Industry Trend Analysis - Sun's US-Centric Focus Faces Challenge
Industry Trend Analysis - Acquisitions Will Stem Cipla's Falling Revenues

Table Of Contents

World Generic Markets 29 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024

Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024

  • $ 4950
  • Industry report
  • November 2016
  • by Grand View Research

The global monoclonal antibodies (mAbs) market was valued at USD 85.4 billion in 2015 and is expected to reach a value of USD 138.6 billion by 2024. Increasing R&D pertaining to the development of therapeutic ...

Global Cancer Monoclonal Antibodies Market

Global Cancer Monoclonal Antibodies Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global cancer monoclonal antibodies market was valued at USD 27 billion for the year 2015 and is expected to grow at a CAGR of around 8-15% from 2016 to 2021. The interaction between a person’s genetic ...

Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2016 Market Research Report

Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Monoclonal Antibody Diagnostic Reagents Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Monoclonal Antibody ...


Download Unlimited Documents from Trusted Public Sources

Protein Industry in the US

  • January 2017
    22 pages
  • Protein  

  • United States  

View report >

Monoclonal Antibody Industry in the US

  • December 2016
    3 pages
  • Prosthesis  

    Monoclonal Anti...  

    Transplantation  

  • United States  

    Europe  

View report >

Pathology Statistics in the US

  • December 2016
    12 pages
  • Monoclonal Anti...  

    Neurological Di...  

  • United States  

View report >

Related Market Segments :

Monoclonal Antibody

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.